Child brain tumor drug trial pulled before it started
NCT ID NCT03554707
First seen May 14, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study was designed for children with brain or spinal cord tumors that came back or did not respond to treatment. It planned to test an experimental drug called SGT-53 alongside radiation and chemotherapy to see if it was safe. However, the study was withdrawn before any patients were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD CNS TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.